News brief­ing: Ax­o­vant re­ports im­proved mo­tor func­tion in small Parkin­son's tri­al; Bain life sci­ences SPAC files for $125M IPO

Ax­o­vant re­port­ed a snap­shot of Phase II fol­low-up da­ta from one co­hort in a small Parkin­son’s dis­ease tri­al Tues­day.

The treat­ment, a gene ther­a­py de­signed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER